Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo (Q28475485)
Jump to navigation
Jump to search
scientific article published on September 3, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo |
scientific article published on September 3, 2010 |
Statements
Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo (English)
0 references
Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo (English)
Jeroen DeGroot
Arno W. R. van Kuijk
Rishma C. Koeman
Dominique L. Baeten
3 September 2010
0 references
5
0 references
9
0 references
e12556
0 references
3 September 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference